After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...
Recursion is using AI to develop new drug candidates much more efficiently than the overall industry. Tempus AI's $1.27 billion trailing revenue comes from a clinical data flywheel that no competitor ...
Abstract: The development of polarization-adjusted convolutional (PAC) codes has introduced a class of efficient designs for short packet transmission. In this contribution, aiming at more flexible ...
Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...
Abstract: Tackling the challenge of open-switch (OS) fault diagnostics in grid-tied three-level neutral point clamped (NPC) inverters with parameter uncertainty, this paper introduces a fault ...